Rapid characterization of the constituents in Jigucao capsule using ultra high performance liquid chromatography with quadrupole time-of-flight mass spectrometry
© 2021 Wiley-VCH GmbH..
Jigucao capsule is a well-known Chinese patent medicine for the treatment of acute and chronic hepatitis and cholecystitis. The chemical components of Jigucao capsule were not clear resulting from the paucity of relevant studies, which hindered the research of the pharmacological mechanism, the comprehensive development, and utilization of Jigucao capsule in clinical studies. By establishing a high-throughput ultra-performance liquid chromatography quadrupole time of flight mass spectrometry in combination with intelligent UNIFI software data processing platform to automatically characterize and identify the chemical profile of Jigucao capsule, 144 compounds were determined rapidly, including 34 terpenoids, 25 flavonoids, 22 steroids, 21 phenylpropanoids, 10 glycosides, six alkaloids, 13 organic acids, and other 13 components. These compounds may be the active components of Jigucao capsule. In this study, a rapid and robust method for comprehensively analyzing the chemical composition of Jigucao capsule was described and established for the first time. The results will provide a reference for the quality control of Jigucao capsule and the establishment of a higher quality standard, as well as for the pharmacodynamic material basis research.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
---|---|
Enthalten in: |
Journal of separation science - 45(2022), 3 vom: 15. Feb., Seite 677-696 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Taiping [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alkaloids |
---|
Anmerkungen: |
Date Completed 07.04.2022 Date Revised 07.04.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/jssc.202100664 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM333598822 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM333598822 | ||
003 | DE-627 | ||
005 | 20231225221956.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/jssc.202100664 |2 doi | |
028 | 5 | 2 | |a pubmed24n1111.xml |
035 | |a (DE-627)NLM333598822 | ||
035 | |a (NLM)34822724 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Taiping |e verfasserin |4 aut | |
245 | 1 | 0 | |a Rapid characterization of the constituents in Jigucao capsule using ultra high performance liquid chromatography with quadrupole time-of-flight mass spectrometry |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.04.2022 | ||
500 | |a Date Revised 07.04.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2021 Wiley-VCH GmbH. | ||
520 | |a Jigucao capsule is a well-known Chinese patent medicine for the treatment of acute and chronic hepatitis and cholecystitis. The chemical components of Jigucao capsule were not clear resulting from the paucity of relevant studies, which hindered the research of the pharmacological mechanism, the comprehensive development, and utilization of Jigucao capsule in clinical studies. By establishing a high-throughput ultra-performance liquid chromatography quadrupole time of flight mass spectrometry in combination with intelligent UNIFI software data processing platform to automatically characterize and identify the chemical profile of Jigucao capsule, 144 compounds were determined rapidly, including 34 terpenoids, 25 flavonoids, 22 steroids, 21 phenylpropanoids, 10 glycosides, six alkaloids, 13 organic acids, and other 13 components. These compounds may be the active components of Jigucao capsule. In this study, a rapid and robust method for comprehensively analyzing the chemical composition of Jigucao capsule was described and established for the first time. The results will provide a reference for the quality control of Jigucao capsule and the establishment of a higher quality standard, as well as for the pharmacodynamic material basis research | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Jigucao capsule | |
650 | 4 | |a component analysis | |
650 | 4 | |a high-throughput analysis | |
650 | 4 | |a quality control | |
650 | 4 | |a traditional Chinese medicine | |
650 | 7 | |a Alkaloids |2 NLM | |
650 | 7 | |a Drugs, Chinese Herbal |2 NLM | |
650 | 7 | |a Flavonoids |2 NLM | |
700 | 1 | |a Zhang, Mengli |e verfasserin |4 aut | |
700 | 1 | |a Tan, Zhien |e verfasserin |4 aut | |
700 | 1 | |a Miao, Jianhua |e verfasserin |4 aut | |
700 | 1 | |a He, Yanmei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Aihua |e verfasserin |4 aut | |
700 | 1 | |a Ou, Min |e verfasserin |4 aut | |
700 | 1 | |a Huang, Danna |e verfasserin |4 aut | |
700 | 1 | |a Wu, Fangfang |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xijun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of separation science |d 2004 |g 45(2022), 3 vom: 15. Feb., Seite 677-696 |w (DE-627)NLM150133529 |x 1615-9314 |7 nnns |
773 | 1 | 8 | |g volume:45 |g year:2022 |g number:3 |g day:15 |g month:02 |g pages:677-696 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/jssc.202100664 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 45 |j 2022 |e 3 |b 15 |c 02 |h 677-696 |